Pharmacy News

Image description

FDA approves Remicade biosimilar

Renflexis, marketed by Merck and developed by South Korea's Samsung Bioepis, is the second FDA-approved biosimilar to Johnson & Johnson’s Remicade.

Image description

First Korean generic to debut in the U.S.

Daewoong Pharmaceutical’s Meroprenem is a generic of Merem, developed by AstraZeneca, as a Carbapenem-series antibiotic widely used in hospitals to treat various ailments ranging from bacterial infections to general diseases.